- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharma
Impax Laboratories Inc+ Add to Watchlist
ILR:GR43.929 EUR 1.636 3.87%
As of 15:51:31 ET on 06/01/2015.
Company Profile for Impax Laboratories Inc (ILR)
Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.
Impax Laboratories Inc
Key Executives for Impax Laboratories Inc (ILR)
|George Frederick Wilkinson "Fred"President/CEO||Michael J NestorPres:Impax Pharmaceuticals|
|Deborah M PenzaSenior VP/Chief Compliance Ofcr||Mark A SchlossbergSenior VP/Secy/General Counsel|
|Bryan M ReasonsSenior VP:Finance/CFO||Donna M HughesSenior VP:Human Resources|
|Jeffrey D Nornhold "Jeff"Senior VP:Technical Operations||Mark DonohueVP:Investor Relations|